Michael Thomas HeffernanDirector
4Rule 10b5-1 plan disclosed
Filed Sep 17, 2026Period of report Sep 15, 20260001193125-26-394456
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
SaleSep 15, 2026 | Common StockF2F1 | 18,321 | $15.09 | $276.46K | 6,451 | Direct |
SaleSep 15, 2026 | Common StockF1 | 100 | $15.88 | $1.59K | 6,351 | Direct |
SaleSep 15, 2026 | Common StockF2F1 | 20,952 | $15.09 | $316.17K | 6,451 | Direct |
SaleSep 15, 2026 | Common StockF1 | 100 | $15.88 | $1.59K | 6,351 | Direct |
Filing footnotes · 6
- F1This exercise of stock options and subsequent sale were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 16, 2026.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.80 to $15.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- F3These options were granted on February 28, 2017. The 18,421 shares of common stock underlying the options vested over four years from the date of grant in equal quarterly installments.
- F4These options, which were awarded on February 28, 2017, would otherwise expire and become forfeitable on February 27, 2027.
- F5These options were granted on December 20, 2017. The 21,052 shares of common stock underlying the options vested over four years from the date of grant in equal quarterly installments.
- F6These options, which were awarded on December 20, 2017, would otherwise expire and become forfeitable on December 19, 2027.